AlgoTherapeutix

About:

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

Top Investors: Bpifrance, Omnes Capital, UI Investissement, Turenne Capital, InnoBio Fund

Description:

AlgoTx creates solutions to help patients suffering from difficult-to-treat conditions. The organization accomplishes this by emphasizing conditions with no proven or licensed therapy and adapting treatment to the very particular needs of the people afflicted. ATX01's admission into Phase 2 in Chemotherapy-Induced Peripheral Neuropathy has been approved by the FDA. In the meanwhile, AlgoTx is investigating its potential in erythromelalgia, a rare and painful condition.

Total Funding Amount:

$37.4M

Headquarters Location:

Suresnes, Ile-de-France, France

Founded Date:

2018-01-01

Contact Email:

contact(AT)algotx.com

Founders:

Olivier Bohuon, Stéphane Thiroloix

Number of Employees:

1-10

Last Funding Date:

2023-03-14

IPO Status:

Private

Industries: